Established in 1982, Choksi Laboratories Ltd has been a pioneer in providing comprehensive contract testing and analytical services. With a proven track record spanning over four decades, the company specializes in analyzing products for clients across diverse industries including pharmaceuticals, food, engineering, and construction materials. As a trusted partner, Choksi Laboratories assists clients in meeting regulatory standards and ensuring product quality and safety.
In this article, we will delve into the history, services, and achievements of Choksi Laboratories Ltd, exploring its pivotal role in analytical testing and its impact on various sectors.
About Choksi Laboratories
Choksi Laboratories Ltd offers a diverse range of specialized services tailored to meet the analytical and regulatory needs of various industries. Under their Contract Laboratory Services (CLS), the company provides comprehensive analysis in four key areas: Pharmaceutical Analysis, Food & Beverages Analysis, Water Analysis, and Construction Material Analysis. Additionally, Choksi Laboratories excels in Instrument Calibration & Validation Services, offering both laboratory and on-site calibration for a wide range of equipment, including consultancy for in-house calibration setups.
Furthermore, the company extends its expertise to Environmental Management Services, assisting industries in developing waste disposal, effluent treatment, air pollution monitoring, and wastewater management strategies. In the realm of Clinical Research, Choksi Laboratories operates a 40-bed facility dedicated to conducting Bio-Availability and Bio-Equivalence studies. The company also offers Consultancy services encompassing training, auditing, and organizational support.
Additionally, Choksi Laboratories has established a hallmarking center equipped with advanced technologies for assaying and hallmarking gold and silver, reflecting their commitment to excellence in analytical services across multiple sectors.
Below are the trading platforms that you can use to purchase Choksi Laboratories shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| May 2024 | 66.10 | 57.47 |
| June 2024 | 68.48 | 59.54 |
| July 2024 | 67.79 | 58.95 |
| August 2024 | 70.50 | 61.31 |
| September 2024 | 73.32 | 63.76 |
| October 2024 | 71.88 | 62.51 |
| November 2024 | 74.04 | 64.38 |
| December 2024 | 75.89 | 65.99 |
Choksi Laboratories Ltd’s share price has shown a steady upward trend from May to December 2024, according to projected maximum and minimum targets. Starting from a minimum of ₹57.47 in May 2024, the share price has steadily climbed, reaching ₹75.89 by December 2024, reflecting positive market sentiment and potential growth prospects. The highest projected price target during this period was ₹75.89, indicating an optimistic outlook for the company’s stock performance.
The current share price of ₹61.2 as of May 15th, 2024, positions the stock within a reasonable range relative to its projected targets and historical highs and lows. With a market capitalization of ₹42.6 Cr. and a Stock P/E ratio of 30.0, Choksi Laboratories demonstrates stability and potential for growth within the industry. The stock’s high/low range of ₹86.0 to ₹36.7 further underscores the volatility and potential returns associated with investing in Choksi Laboratories Ltd.
| When | Maximum Price | Minimum Price |
| January 2025 | 77.41 | 59.55 |
| February 2025 | 79.40 | 61.07 |
| March 2025 | 82.49 | 63.45 |
| April 2025 | 80.87 | 62.21 |
| May 2025 | 78.52 | 60.40 |
| June 2025 | 82.05 | 63.12 |
| July 2025 | 80.44 | 61.88 |
| August 2025 | 82.93 | 63.79 |
| September 2025 | 85.83 | 66.03 |
| October 2025 | 88.07 | 67.74 |
| November 2025 | 90.27 | 69.44 |
| December 2025 | 92.52 | 71.17 |
In 2025, Choksi Laboratories Ltd’s share price targets continue to project strong growth throughout the year. Starting from a minimum target of ₹59.55 in January, the share price is expected to reach a maximum target of ₹92.52 by December. This optimistic trajectory suggests a positive outlook for investors, with consistent monthly increases in projected prices.
The company’s diverse clientele, which includes over 1000 customers such as IPCA Labs, Nicholas Piramal India Ltd., Serum Institute of India, Famycare India, EID Parry, and Cummins India Ltd., underscores its reputation and broad industry reach. With a solid customer base and robust growth projections, Choksi Laboratories appears poised for continued success in 2025.
| When | Maximum Price | Minimum Price |
| January 2026 | 95.30 | 73.31 |
| February 2026 | 97.74 | 75.19 |
| March 2026 | 101.55 | 78.12 |
| April 2026 | 99.56 | 76.59 |
| May 2026 | 96.66 | 74.36 |
| June 2026 | 101.01 | 77.70 |
| July 2026 | 99.03 | 76.18 |
| August 2026 | 102.10 | 78.53 |
| September 2026 | 105.67 | 81.28 |
| October 2026 | 108.42 | 83.40 |
| November 2026 | 111.13 | 85.48 |
| December 2026 | 113.90 | 87.62 |
In 2026, Choksi Laboratories Ltd’s share price targets demonstrate a continued upward trajectory, reflecting strong growth prospects throughout the year. The projected maximum share price ranges from ₹95.30 in January to ₹113.90 by December, with corresponding minimum targets indicating steady appreciation. This optimistic outlook aligns with the company’s impressive achievements and industry-first initiatives.
Choksi Laboratories has pioneered vendor assessment programs in the edible oil extraction industry, introduced water and soil analysis services in Central India, and spearheaded instrument calibration services for ISO-certified organizations. These achievements underscore the company’s innovative approach and commitment to quality, positioning Choksi Laboratories as a leader in analytical services with potential for sustained market value growth.
| When | Maximum Price | Minimum Price |
| January 2027 | 116.18 | 89.37 |
| February 2027 | 119.16 | 91.66 |
| March 2027 | 123.81 | 95.24 |
| April 2027 | 121.38 | 93.37 |
| May 2027 | 117.85 | 90.65 |
| June 2027 | 123.15 | 94.73 |
| July 2027 | 120.73 | 92.87 |
| August 2027 | 124.47 | 95.75 |
| September 2027 | 128.83 | 99.10 |
| October 2027 | 132.17 | 101.67 |
| November 2027 | 135.48 | 104.21 |
| December 2027 | 138.87 | 106.82 |
In 2027, Choksi Laboratories Ltd’s share price targets project robust growth and appreciation over the course of the year. The maximum projected share price climbs from ₹116.18 in January to ₹138.87 by December, reflecting sustained investor confidence and positive market sentiment. Similarly, the minimum price targets also demonstrate steady upward movement, indicating overall strength in the stock’s performance.
Choksi Laboratories continues to leverage its expertise and reputation in the industry, evident from its significant revenue generation in FY21 primarily through service rendering. This underscores the company’s core competency in delivering high-quality analytical and testing services, contributing to its financial success and potential for continued expansion in 2027. With promising share price targets and a solid revenue base, Choksi Laboratories remains well-positioned for growth and value creation in the coming year.
| When | Maximum Price | Minimum Price |
| January 2028 | 141.64 | 108.96 |
| February 2028 | 145.28 | 111.75 |
| March 2028 | 150.94 | 116.11 |
| April 2028 | 147.98 | 113.83 |
| May 2028 | 143.67 | 110.52 |
| June 2028 | 150.14 | 115.49 |
| July 2028 | 147.19 | 113.22 |
| August 2028 | 151.74 | 116.73 |
| September 2028 | 157.06 | 120.81 |
| October 2028 | 161.14 | 123.95 |
| November 2028 | 165.17 | 127.05 |
| December 2028 | 169.30 | 130.23 |
- January 2028: ₹108.96 (Minimum)
- December 2028: ₹169.30 (Maximum)
| When | Maximum Price | Minimum Price |
| January 2029 | 172.68 | 132.83 |
| February 2029 | 177.11 | 136.24 |
| March 2029 | 184.02 | 141.55 |
| April 2029 | 180.41 | 138.78 |
| May 2029 | 175.16 | 134.73 |
| June 2029 | 183.04 | 140.80 |
| July 2029 | 179.45 | 138.04 |
| August 2029 | 185.00 | 142.31 |
| September 2029 | 191.47 | 147.29 |
| October 2029 | 196.45 | 151.12 |
| November 2029 | 201.36 | 154.89 |
| December 2029 | 206.40 | 158.77 |
- January 2029: ₹132.83(Minimum)
- December 2029: ₹206.40 (Maximum)
| When | Maximum Price | Minimum Price |
| January 2030 | 210.52 | 161.94 |
| February 2030 | 215.92 | 166.09 |
| March 2030 | 224.34 | 172.57 |
| April 2030 | 219.94 | 169.19 |
| May 2030 | 213.54 | 164.26 |
| June 2030 | 223.15 | 171.65 |
| July 2030 | 218.77 | 168.29 |
| August 2030 | 225.54 | 173.49 |
| September 2030 | 233.43 | 179.56 |
| October 2030 | 239.50 | 184.23 |
| November 2030 | 245.49 | 188.84 |
| December 2030 | 251.63 | 193.56 |
- January 2030: ₹161.94 (Minimum)
- December 2030: ₹251.63 (Maximum)
Financial Condition of Choksi Laboratories: Last 5 Years
| Financials | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Sales (in Rs. Crores) | 33.74 | 28.16 | 25.69 | 30.04 | 34.44 |
| Expenses (in Rs. Crores) | 26.48 | 24.62 | 21.57 | 21.14 | 24.17 |
| Operating Profit (in Rs. Crores) | 7.26 | 3.54 | 4.12 | 8.90 | 10.27 |
| Other Income (in Rs. Crores) | 0.25 | -2.80 | 0.49 | 0.12 | 2.47 |
| Interest (in Rs. Crores) | 1.54 | 1.89 | 2.82 | 3.23 | 3.52 |
| Depreciation (in Rs. Crores) | 3.68 | 4.56 | 4.60 | 5.43 | 5.50 |
| Profit before Tax (in Rs. Crores) | 2.29 | -5.71 | -2.81 | 0.36 | 3.72 |
| Net Profit (in Rs. Crores) | 1.60 | -3.88 | -2.61 | 0.21 | 3.21 |
| EPS (in Rs) | 2.30 | -5.57 | -3.75 | 0.30 | 4.61 |
Over the last five years, Choksi Laboratories has experienced fluctuations in its financial performance. Sales decreased from 33.74 crores in 2019 to 25.69 crores in 2021 before rebounding to 34.44 crores in 2023, indicating some volatility in revenue. Despite declining sales in certain years, the company’s operating profit demonstrated a positive trend, notably increasing from 7.26 crores in 2019 to 10.27 crores in 2023, reflecting improved operational efficiency.
However, the company faced challenges such as negative net profits in 2020 and 2021 (-3.88 crores and -2.61 crores, respectively), followed by a recovery to 3.21 crores in 2023. Earnings per share (EPS) also showed variability, turning negative in 2020 and 2021 before rebounding to 4.61 rupees in 2023.
Despite recent fluctuations, Choksi Laboratories has demonstrated resilience over the long term with a compounded sales growth rate of 7% over the past 10 years, although the recent trend has been slower (1% in TTM). Similarly, compounded profit growth has been stable over 10 years and 5 years, with notable growth of 61% over the past 3 years. The company’s stock price has shown significant appreciation, particularly in the last 3 years (87% CAGR), indicating investor confidence in its future prospects. Return on equity (ROE) has improved in the last year to 8%, reflecting positive momentum in profitability and shareholder returns.
FAQs
What is the market capitalization of Choksi Laboratories?
Choksi Laboratories currently boasts a market capitalization of ₹42.6 Crores.
As of May 15th, 2024, the share price of Choksi Laboratories stands at ₹61.2.
In 2025, Choksi Laboratories’ share price targets range from a low of ₹59.55 in January to a high of ₹92.52 by December.
Looking ahead to 2030, Choksi Laboratories’ share price is expected to range from ₹161.94 (minimum) in January to ₹251.63 (maximum) by December.
What is the current P/E (Price/Earnings) ratio of Choksi Laboratories?
Choksi Laboratories’ current P/E ratio is 30.0, indicating a solid position within the market.
How has Choksi Laboratories’ stock price performed historically?
Over recent periods, Choksi Laboratories has demonstrated a high/low range of ₹86.0 (peak) to ₹36.7 (trough), reflecting both potential returns and market volatility.
What percentage of dividends does Choksi Laboratories pay out?
Choksi Laboratories has a dividend payout percentage of 0.00%.
How has Choksi Laboratories’ revenue trended over the last five years?
Choksi Laboratories’ revenue initially declined but rebounded to ₹34.44 Crores in 2023, showcasing resilience and recovery.
How has Choksi Laboratories’ operating profit evolved in recent years?
Choksi Laboratories’ operating profit has risen steadily from ₹7.26 Crores in 2019 to ₹10.27 Crores in 2023, highlighting improved operational efficiency.
What is the return on equity (ROE) trend for Choksi Laboratories?
ROE has shown positive improvement, particularly in the last year, reaching 8%.
Also Read
- Piramal Pharma Share Price Target 2024, 2025 to 2030
- ZOMATO SHARE PRICE TARGET 2024, 2025, 2026 TO 2030
- MAHINDRA AND MAHINDRA SHARE PRICE TARGET 2024, 2025, 2026 to 2030
In conclusion, Choksi Laboratories Ltd, established in 1982, has established itself as a pioneer in analytical testing services across diverse industries. Despite facing challenges such as a low interest coverage ratio and modest sales growth of 2.53% over the past five years, the company has demonstrated resilience through improving operating profits and a positive trend in return on equity (ROE) over the last year, reaching 8%.
Looking forward, Choksi Laboratories projects optimistic share price targets until 2030, indicating potential growth opportunities for investors. However, it’s important to note certain aspects such as the absence of dividend payouts, low promoter holding (31.5%), and historical stock price volatility.
With a market capitalization of ₹42.6 Crores and a reasonable P/E ratio of 30.0, Choksi Laboratories is positioned for growth, but investors should carefully consider the company’s financial performance and market conditions before making investment decisions.
In summary, Choksi Laboratories Ltd remains a significant player in analytical services, navigating challenges while showing promising growth prospects. Investors should assess the company’s financial health and strategic direction for a comprehensive understanding of its investment potential.
What did we learn?
- 1 About Choksi Laboratories
- 2 How to Purchase Choksi Laboratories Shares in India?
- 3 Choksi Laboratories Share Price Prediction: 2024 – 2030
- 3.1 Choksi Laboratories Share Price Target 2024
- 3.2 Choksi Laboratories Share Price Target 2025
- 3.3 Choksi Laboratories Share Price Target 2026
- 3.4 Choksi Laboratories Share Price Target 2027
- 3.5 Choksi Laboratories Share Price Target 2028
- 3.6 Choksi Laboratories Share Price Target 2029
- 3.7 Choksi Laboratories Share Price Target 2030
- 4 Financial Condition of Choksi Laboratories: Last 5 Years
- 5 FAQs
- 5.1 What is the market capitalization of Choksi Laboratories?
- 5.2 What is the latest share price of Choksi Laboratories?
- 5.3 What are the projected share price targets for Choksi Laboratories in 2025?
- 5.4 What is the anticipated share price outlook for Choksi Laboratories in 2030?
- 5.5 What is the current P/E (Price/Earnings) ratio of Choksi Laboratories?
- 5.6 How has Choksi Laboratories’ stock price performed historically?
- 5.7 What percentage of dividends does Choksi Laboratories pay out?
- 5.8 How has Choksi Laboratories’ revenue trended over the last five years?
- 5.9 How has Choksi Laboratories’ operating profit evolved in recent years?
- 5.10 What is the return on equity (ROE) trend for Choksi Laboratories?
- 6 Conclusion: Navigating Challenges and Promising Growth
